55.37 -0.28 (-0.50%)
4:00 PM ET 11/24/09
Company Profile
Price and Volume
Recent Price 55.65
52 Week High 58.31
52 Week Low 36.90
Avg. Daily Vol. (Mil) 3.31
Beta (3 year) 0.42
Share Related Items
Mkt Cap (Mil) 25,576.87
Shares Out (Mil) 459.60
Float (Mil) 457.03
Dividend Information
Yield % 0.00
Annual Dividend 0.00
Payout Ratio 0.00
Financial Strength
Quick Ratio 6.50
Current Ratio 7.10
LT Debt/ Equity 0.00
Total Debt / Equity 0.00
Valuation Ratios
Price Earnings 67.00
Price/Sales 10.00
Price/Book 6.22
Price/Cash Flow 49.50
Per Share Data
Earnings 0.83
Sales 5.56
Book Value 8.94
Cash Flow 1.12
Business Summary
A biopharmaceutical company, which is engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases.
General Information
86 Morris Avenue
Summit, NJ 07901
www.celgene.com
Industry : Drugs
Sector: Health Care
Employees: 2441
CEO: Dr. Sol J. Barer, Ph.D.
Short Interest
Current Month (Mil) 7.37
Previous Month (Mil) 7.73
Short Interest Ratio (Days) 2.00
Management Effectiveness
Return on Equity 9.10
Return on Assets 7.30
Return on Investments 9.10
Profitability
Gross Margin 92.70
EBIT Margin 22.40
Profit Margin 14.60
Dow Jones S&P 500 NASDAQ 10-Year Note
10,433.71 1,105.65 2,169.18 33.17
Oil *
76.42
DOWN
17.24
DOWN
0.59
DOWN
6.83
DOWN
0.47
10 Yr
3.32%
SPDR Gold
114.73
-0.16%
-0.05%
-0.31%
-1.40%
Data delayed 20 minutes

Brokerage Partners

TheStreet Premium Services

All Services